ProShare Advisors’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$23.9K Sell
2024
Q4
$28.1K Buy
2024
Q3
$18.7K Buy
2016
Q4
Sell
2016
Q3
$123K Sell
2016
Q2
$127K Buy
2016
Q1
$294K Sell
2015
Q4
$403K Buy
2015
Q3
$277K Sell
2015
Q2
$486K Buy
2015
Q1
$740K Buy
2014
Q4
$569K Buy
2014
Q3
$190K Sell
2014
Q2
$265K Sell
2014
Q1
$391K Buy
2013
Q4
$141K Buy